BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31590721)

  • 1. Dynamic Functional Connectivity: A New Perspective on 22q11.2 Deletion Syndrome and Psychosis.
    Schmitt JE
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Oct; 4(10):852-853. PubMed ID: 31590721
    [No Abstract]   [Full Text] [Related]  

  • 2. Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Hooper SR; Shashi V
    Schizophr Res; 2017 Oct; 188():33-34. PubMed ID: 28768602
    [No Abstract]   [Full Text] [Related]  

  • 3. 22q11.2 Deletion Syndrome: Characterization of Psychosis Spectrum and Future Directions.
    Radoeva PD
    Biol Psychiatry; 2017 Jul; 82(1):e5-e7. PubMed ID: 28619254
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.
    Eisenberg DP; Gregory MD; Berman KF
    Am J Psychiatry; 2020 Jul; 177(7):564-566. PubMed ID: 32605438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
    Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
    Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
    Goes FS; Sawa A
    Am J Psychiatry; 2017 Nov; 174(11):1027-1029. PubMed ID: 29088933
    [No Abstract]   [Full Text] [Related]  

  • 8. A Better Understanding of Brain Involvement in 22q11.2 Deletion Syndrome.
    Del Giudice E
    Pediatr Neurol; 2018 Jan; 78():e5. PubMed ID: 29167055
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Correspondence on "A Better Understanding of Brain Involvement in 22q11.2 Deletion Syndrome".
    Mudigoudar B; Wheless JW
    Pediatr Neurol; 2018 Jan; 78():e7. PubMed ID: 29174003
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Anomalies in 22q11.2 Deletion (DiGeorge syndrome): From Copy Number Variations to Single-Gene Determinants of Phenotype.
    Hall G; Routh JC; Gbadegesin RA
    Am J Kidney Dis; 2017 Jul; 70(1):8-10. PubMed ID: 28456345
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune Biomarkers of Autoimmunity in Chromosome 22q11.2 Deletion Syndrome.
    Sullivan KE
    J Allergy Clin Immunol Pract; 2019; 7(7):2377-2378. PubMed ID: 31495434
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical management of psychosis in 22q11.2 deletion syndrome.
    Iftimovici A; Krebs MO; Chaumette B
    J Psychiatry Neurosci; 2022; 47(6):E391-E392. PubMed ID: 36347546
    [No Abstract]   [Full Text] [Related]  

  • 14. From Gene to Brain and Behavior: Excitatory and Inhibitory Imbalance and Psychosis in Individuals With 22q11.2 Deletion Syndrome.
    Rogdaki M
    Biol Psychiatry; 2023 Oct; 94(7):526-527. PubMed ID: 37673515
    [No Abstract]   [Full Text] [Related]  

  • 15. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
    J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome.
    Midbari Kufert Y; Nachmani A; Nativ E; Weizman A; Gothelf D
    J Neural Transm (Vienna); 2016 Dec; 123(12):1491-1497. PubMed ID: 27517838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson's disease?
    Fung W; Peall KJ
    J Neurol; 2018 Oct; 265(10):2463-2465. PubMed ID: 30238269
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome.
    Swillen A
    Curr Opin Psychiatry; 2016 Mar; 29(2):133-7. PubMed ID: 26779858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.